Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Conget

Showing results (21-30 of 98) with videos related to

Pageof 10
Sort By:
Diabetes Research and Clinical Practice|November 26, 1998
High prevalence of abnormal glucose tolerance and metabolic disturbances in first degree relatives of NIDDM patients. A study in Catalonia, a mediterranean communityA Costa, M Rios, R Casamitjana, et al.
Acta Diabetologica|February 14, 2008
Phenotype changes at the onset of type 1 diabetes in young adults from a mediterranean area throughout the last decadeM Giménez, J Nicolau, J Vidal, et al.
Revista Clinica Espanola|January 12, 2001
[Prevalence and distribution of cardiovascular risk factors in the population of a metropolitan area]]J J Poley García, A Costa Ferrer, I Conget Donlo
Lancet (London, England)|November 19, 1988
Diabetes in AIDS patientsJ Vendrell, I Conget, A Muñoz, et al.
The American Journal of Physiology|April 1, 1995
SAM prevents impairment of glucose-stimulated insulin secretion caused by hexose deprivation or starvationI Conget, T M Zhang, D L Eizirik, et al.
Diabetes Research and Clinical Practice|November 6, 1989
Effect of treatment with an inhibitor of platelet aggregation on the evolution of background retinopathy: 2 years of follow-upE Esmatjes, M Maseras, M Gállego, et al.
BMC Sports Science, Medicine & Rehabilitation|July 25, 2023
Physical activity patterns in type 1 diabetes in Spain: The SED1 studyF Gómez-Peralta, E Menéndez, S Conde, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 6, 1999
Effects of insulin administration in a group of high-risk, non-diabetic, first-degree relatives of Type 1 diabetic patients: an open pilot trialC Rodríguez-Villar, I Conget, R Casamitjana, et al.
AIDS (London, England)|June 5, 1999
Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapineE Martínez, I Conget, L Lozano, et al.
Diabetes Research and Clinical Practice|July 1, 1996
Coenzyme Q10 and insulin secretion in vitroI Conget, J M Manzanares, A Barrientos, et al.
Pageof 10

Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
Diabetes Research and Clinical Practice|November 26, 1998
High prevalence of abnormal glucose tolerance and metabolic disturbances in first degree relatives of NIDDM patients. A study in Catalonia, a mediterranean communityA Costa, M Rios, R Casamitjana, et al.
Acta Diabetologica|February 14, 2008
Phenotype changes at the onset of type 1 diabetes in young adults from a mediterranean area throughout the last decadeM Giménez, J Nicolau, J Vidal, et al.
Revista Clinica Espanola|January 12, 2001
[Prevalence and distribution of cardiovascular risk factors in the population of a metropolitan area]]J J Poley García, A Costa Ferrer, I Conget Donlo
Lancet (London, England)|November 19, 1988
Diabetes in AIDS patientsJ Vendrell, I Conget, A Muñoz, et al.
The American Journal of Physiology|April 1, 1995
SAM prevents impairment of glucose-stimulated insulin secretion caused by hexose deprivation or starvationI Conget, T M Zhang, D L Eizirik, et al.
Diabetes Research and Clinical Practice|November 6, 1989
Effect of treatment with an inhibitor of platelet aggregation on the evolution of background retinopathy: 2 years of follow-upE Esmatjes, M Maseras, M Gállego, et al.
BMC Sports Science, Medicine & Rehabilitation|July 25, 2023
Physical activity patterns in type 1 diabetes in Spain: The SED1 studyF Gómez-Peralta, E Menéndez, S Conde, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 6, 1999
Effects of insulin administration in a group of high-risk, non-diabetic, first-degree relatives of Type 1 diabetic patients: an open pilot trialC Rodríguez-Villar, I Conget, R Casamitjana, et al.
AIDS (London, England)|June 5, 1999
Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapineE Martínez, I Conget, L Lozano, et al.
Diabetes Research and Clinical Practice|July 1, 1996
Coenzyme Q10 and insulin secretion in vitroI Conget, J M Manzanares, A Barrientos, et al.
Pageof 10